Evidence map›Paper›PMID 23648141›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2013

Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.

Yoshito Tomimaru, Chelsea Q Xu, Sarah B Nambotin, Tao Yan, Jack R Wands, Miran Kim

Open access · greenAbstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Associations between serum HBX quasispecies and their integration in hepatocellular carcinoma.International journal of clinical and experimental pathology · 2017
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yoshito TomimaruLiver Research Center, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Chelsea Q Xu
Sarah B Nambotin
Tao Yan
Jack R Wands
Miran Kim
Brown University · US

Funding

WNT SIGNALING IN HEPATOCELLULAR CARCINOMAP20RR015578 · NCRR · BROWN UNIVERSITY · PI THOMPSON, WILLIAM ALBERT · 2000 to 2009
$22.8M
Biomarker for Hepatocellular CarcinomaR01CA123544 · NCI · RHODE ISLAND HOSPITAL · PI WANDS, JACK R · 2007 to 2011
$1.2M
ROLE OF WNT SIGNALING IN CHRONIC ALCOHOLIC LIVER DISEASER21AA020587 · NIAAA · RHODE ISLAND HOSPITAL · PI KIM, MIRAN · 2012 to 2013
$404k
NCI NIH HHS CA123544NCI NIH HHS R01 CA123544NCRR NIH HHS P20 RR015578NIAAA NIH HHS AA020587NIAAA NIH HHS R21 AA020587
6 · The paper itself

Abstract

backgroundT-cell factor (TCF) proteins represent key transcription factors that activate Wnt/β-catenin signalling. We have reported that a pair of TCF-4 isoforms (TCF-4C and TCF-4D) exhibit differential TCF transcriptional activity in hepatocellular carcinoma (HCC) cells, although their structure differs by only the presence (TCF-4D) or absence (TCF-4C) of exon 4.

aimTo demonstrate a regulatory role of exon 4 in HCC development.

methodsTCF-4C and TCF-4D expression profiles were examined in 27 pairs of human HCC and adjacent liver tissues. The functional role of the TCF-4 isoforms was evaluated in OUMS-29 (an immortalized hepatocyte-derived) and HAK-1A (a well-differentiated HCC) cell lines using stable clones overexpressing the TCF-4 isoforms.

resultsTCF-4C was significantly upregulated in HCC tissues compared with corresponding peritumour and normal liver tissues; in contrast, there was no difference in TCF-4D expression. TCF-4C clones derived from both cell lines exhibited increased TCF activity, Wnt-responsive target genes, cell proliferation, cell cycle progression and resistance to chemotherapeutic drugs compared with TCF-4D clones. Capability of cell migration and colony formation was significantly higher in TCF-4C than TCF-4D clones. In a nude mice xenograft model, the HAK-1A-derived TCF-4C clone rapidly developed tumours compared with the TCF-4D clone. TCF-4C clone-derived tumours exhibited upregulation of Wnt-responsive target genes compared with the slow developing and small TCF-4D-derived tumours.

conclusionThese results demonstrate that the TCF-4C isoform lacking exon 4 is associated with a malignant phenotype compared with the exon 4-harbouring TCF-4D isoform, indicating that exon 4 of TCF-4 plays a prominent role in HCC development.

Indexed as

AnimalsBlotting, WesternCarcinoma, HepatocellularCell CycleCell Line, TumorCell MovementCell ProliferationColony-Forming Units AssayExonsFluorescent Antibody TechniqueGene Expression ProfilingHumansImmunoprecipitationLiver NeoplasmsMiceMice, NudeProtein IsoformsTCF7L2 protein, humanTranscription Factor 7-Like 2 Proteinexon 4hepatocellular carcinomaisoformT-cell factor-4Wnt

Identifiers

PMID23648141
PMCPMC3775864
OpenAlexW2047857301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.